Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin

被引:484
作者
Péterfy, M
Phan, J
Xu, P
Reue, K [1 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[2] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
关键词
D O I
10.1038/83685
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mice carrying mutations in the fatty liver dystrophy (fld) gene have features of human lipodystrophy(1), a genetically heterogeneous group of disorders characterized by loss of body fat, fatty liver hypertriglyceridemia and insulin resistance(2-4). Through positional cloning, we have isolated the gene responsible and characterized two independent mutant alleles, fld and fld(2J). The gene (Lpin1) encodes a novel nuclear protein which we have named lipin. Consistent with the observed reduction of adipose tissue mass in fld and fld(2J) mice, wild-type Lpin1 mRNA is expressed at high levels in adipose tissue and is induced during differentiation of 3T3-L1 pre-adipocytes. Our results indicate that lipin is required for normal adipose tissue development, and provide a candidate gene for human lipodystrophy. Lipin defines a novel family of nuclear proteins containing at least three members in mammalian species, and homologs in distantly related organisms from human to yeast.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 26 条
[1]   CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT [J].
AILHAUD, G ;
GRIMALDI, P ;
NEGREL, R .
ANNUAL REVIEW OF NUTRITION, 1992, 12 :207-233
[2]   Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy [J].
Cao, H ;
Hegele, RA .
HUMAN MOLECULAR GENETICS, 2000, 9 (01) :109-112
[3]   A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2 [J].
Comuzzie, AG ;
Hixson, JE ;
Almasy, L ;
Mitchell, BD ;
Mahaney, MC ;
Dyer, TD ;
Stern, MP ;
MacCluer, JW ;
Blangero, J .
NATURE GENETICS, 1997, 15 (03) :273-276
[4]   A physical map of 30,000 human genes [J].
Deloukas, P ;
Schuler, GD ;
Gyapay, G ;
Beasley, EM ;
Soderlund, C ;
Rodriguez-Tomé, P ;
Hui, L ;
Matise, TC ;
McKusick, KB ;
Beckmann, JS ;
Bentolila, S ;
Bihoreau, MT ;
Birren, BB ;
Browne, J ;
Butler, A ;
Castle, AB ;
Chiannilkulchai, N ;
Clee, C ;
Day, PJR ;
Dehejia, A ;
Dibling, T ;
Drouot, N ;
Duprat, S ;
Fizames, C ;
Fox, S ;
Gelling, S ;
Green, L ;
Harrison, P ;
Hocking, R ;
Holloway, E ;
Hunt, S ;
Keil, S ;
Lijnzaad, P ;
Louis-Dit-Sully, C ;
Ma, J ;
Mendis, A ;
Miller, J ;
Morissette, J ;
Muselet, D ;
Nusbaum, HC ;
Peck, A ;
Rozen, S ;
Simon, D ;
Slonim, DK ;
Staples, R ;
Stein, LD ;
Stewart, EA ;
Suchard, MA ;
Thangarajah, T ;
Vega-Czarny, N .
SCIENCE, 1998, 282 (5389) :744-746
[5]  
DORFLER H, 1993, CLIN INVESTIGATOR, V71, P264
[6]   A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10 [J].
Hager, J ;
Dina, C ;
Francke, S ;
Dubois, S ;
Houari, M ;
Vatin, V ;
Vaillant, E ;
Lorentz, N ;
Basdevant, A ;
Clement, K ;
Guy-Grand, B ;
Froguel, P .
NATURE GENETICS, 1998, 20 (03) :304-308
[7]   LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration [J].
Hegele, RA ;
Cao, HN ;
Huff, MW ;
Anderson, CM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3089-3093
[8]   Altered gene expression pattern in the fatty liver dystrophy mouse reveals impaired insulin-mediated cytoskeleton dynamics [J].
Klingenspor, M ;
Xu, P ;
Cohen, RD ;
Welch, C ;
Reue, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23078-23084
[9]  
LANGNER CA, 1991, J BIOL CHEM, V266, P11955
[10]  
LANGNER CA, 1989, J BIOL CHEM, V264, P7994